Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Colorectal Neoplasms

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 104 articles:
HTML format



Single Articles


    August 2022
  1. WELLS CI, Varghese C, Boyle LJ, McGuinness MJ, et al
    "Failure to Rescue" following Colorectal Cancer Resection: Variation and Improvements in a National Study of Postoperative Mortality: Reducing Mortality after Colorectal Surgery.
    Ann Surg. 2022 Aug 3. pii: 00000658-990000000-00207.
    PubMed     Abstract available


    July 2022
  2. BOSCH F, Ren H, Pretzsch E, Jacob S, et al
    Identification of an EMT-related Gene Signature Predicting Recurrence in Stage II/III Colorectal Cancer - A Retrospective Study in 1780 Patients.
    Ann Surg. 2022 Jul 26. pii: 00000658-990000000-00186.
    PubMed     Abstract available


  3. ZHAO Y, Peng F, Wang C, Murano T, et al
    A DNA Methylation-Based Epigenetic Signature for the Identification of Lymph Node Metastasis in T1 Colorectal Cancer.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00144.
    PubMed     Abstract available


  4. LEE BM, Chang JS, Koom WS, Byun HK, et al
    Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal Cancer.
    Ann Surg. 2022 Jul 15. pii: 00000658-990000000-00109.
    PubMed     Abstract available


  5. VARGHESE C, Wells CI, O'Grady G, Christensen P, et al
    The Longitudinal Course of Low-anterior Resection Syndrome: An individual Patient Meta-analysis.
    Ann Surg. 2022;276:46-54.
    PubMed     Abstract available


  6. VAN DER HEIJDEN JAG, Kalkdijk-Dijkstra AJ, Pierie JPEN, van Westreenen HL, et al
    Pelvic Floor Rehabilitation After Rectal Cancer Surgery: A Multicenter Randomized Clinical Trial (FORCE Trial).
    Ann Surg. 2022;276:38-45.
    PubMed     Abstract available


  7. ISHIBE A, Watanabe J, Suwa Y, Nakagawa K, et al
    A Prospective, Single-arm, Multicenter Trial of Diverting Stoma Followed by Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE Study).
    Ann Surg. 2022;276:140-145.
    PubMed     Abstract available


    June 2022
  8. HANNA GB, Mackenzie H, Miskovic D, Ni M, et al
    Laparoscopic Colorectal Surgery Outcomes Improved After National Training Program (LAPCO) for Specialists in England.
    Ann Surg. 2022;275:1149-1155.
    PubMed     Abstract available


  9. SONG Y, Shannon AB, Concors SJ, Roses RE, et al
    Are Volume Pledge Standards Worth the Travel Burden for Major Abdominal Cancer Operations?
    Ann Surg. 2022;275:e743-e751.
    PubMed     Abstract available


    May 2022
  10. LEICHER LW, Huisman JF, van Grevenstein WMU, Didden P, et al
    Colonoscopic-Assisted Laparoscopic Wedge Resection for Colonic Lesions: A Prospective Multicenter Cohort Study (LIMERIC-Study).
    Ann Surg. 2022;275:933-939.
    PubMed     Abstract available


    April 2022
  11. YUAN Z, Xu T, Cai J, Zhao Y, et al
    Development and Validation of an Image-based Deep Learning Algorithm for Detection of Synchronous Peritoneal Carcinomatosis in Colorectal Cancer.
    Ann Surg. 2022;275:e645-e651.
    PubMed     Abstract available


  12. KUDOSE Y, Shida D, Ahiko Y, Nakamura Y, et al
    Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort.
    Ann Surg. 2022;275:727-734.
    PubMed     Abstract available


    February 2022
  13. ECKER BL, Shin P, Saadat LV, Court CM, et al
    Genomic Stratification of Resectable Colorectal Liver Metastasis Patients and Implications for Adjuvant Therapy and Survival.
    Ann Surg. 2022;275:371-381.
    PubMed     Abstract available


  14. ROULEAU FOURNIER F, Motamedi MAK, Brown CJ, Phang T, et al
    Oncologic Outcomes Associated With MRI-detected Extramural Venous Invasion (mrEMVI) in Rectal Cancer: A Systematic Review and Meta-analysis.
    Ann Surg. 2022;275:303-314.
    PubMed     Abstract available


  15. BERKEL AEM, Bongers BC, Kotte H, Weltevreden P, et al
    Effects of Community-based Exercise Prehabilitation for Patients Scheduled for Colorectal Surgery With High Risk for Postoperative Complications: Results of a Randomized Clinical Trial.
    Ann Surg. 2022;275:e299-e306.
    PubMed     Abstract available


  16. PEREZ NP, Baez YA, Stapleton SM, Muniappan A, et al
    Racially Conscious Cancer Screening Guidelines: A Path Towards Culturally Competent Science.
    Ann Surg. 2022;275:259-270.
    PubMed     Abstract available


  17. KOEDAM TWA, Bootsma BT, Deijen CL, van de Brug T, et al
    Oncological Outcomes After Anastomotic Leakage After Surgery for Colon or Rectal Cancer: Increased Risk of Local Recurrence.
    Ann Surg. 2022;275:e420-e427.
    PubMed     Abstract available


  18. BAUER PS, Chapman WC Jr, Atallah C, Makhdoom BA, et al
    Perioperative Complications After Proctectomy for Rectal Cancer: Does Neoadjuvant Regimen Matter?
    Ann Surg. 2022;275:e428-e432.
    PubMed     Abstract available


    January 2022
  19. BLOK RD, Sharabiany S, Stoker J, Laan ETM, et al
    Cumulative 5-year Results of a Randomized Controlled Trial Comparing Biological Mesh With Primary Perineal Wound Closure After Extralevator Abdominoperineal Resection (BIOPEX-study).
    Ann Surg. 2022;275:e37-e44.
    PubMed     Abstract available


  20. BENEDETTI CACCIAGUERRA A, Gorgec B, Cipriani F, Aghayan D, et al
    Risk Factors of Positive Resection Margin in Laparoscopic and Open Liver Surgery for Colorectal Liver Metastases: A New Perspective in the Perioperative Assessment: A European Multicenter Study.
    Ann Surg. 2022;275:e213-e221.
    PubMed     Abstract available


  21. HUISMAN DE, Reudink M, van Rooijen SJ, Bootsma BT, et al
    LekCheck: A Prospective Study to Identify Perioperative Modifiable Risk Factors for Anastomotic Leakage in Colorectal Surgery.
    Ann Surg. 2022;275:e189-e197.
    PubMed     Abstract available


  22. RONNOW CF, Arthursson V, Toth E, Krarup PM, et al
    Lymphovascular Infiltration, Not Depth of Invasion, is the Critical Risk Factor of Metastases in Early Colorectal Cancer: Retrospective Population-based Cohort Study on Prospectively Collected Data, Including Validation.
    Ann Surg. 2022;275:e148-e154.
    PubMed     Abstract available


  23. SABBAGH C, Manceau G, Mege D, Abdalla S, et al
    Is Adjuvant Chemotherapy Necessary for Obstructing Stage II Colon Cancer? Results From a Propensity Score Analysis of the French Surgical Association Database.
    Ann Surg. 2022;275:149-156.
    PubMed     Abstract available


  24. KOH CE, Brown KGM, Steffens D, Young J, et al
    What Constitutes a Clear Margin in Patients With Locally Recurrent Rectal Cancer Undergoing Pelvic Exenteration?
    Ann Surg. 2022;275:157-165.
    PubMed     Abstract available


    December 2021
  25. POULSON M, Geary AD, Annesi C, Dechert T, et al
    The Impact of Income and Social Mobility on Colorectal Cancer Outcomes and Treatment: A Cross-sectional Study.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93134.
    PubMed     Abstract available


  26. PYO DH, Kim SH, Ha SY, Yun SH, et al
    Revised Nodal Staging Integrating Tumor Deposit Counts With Positive Lymph Nodes in Patients With Stage III Colon Cancer.
    Ann Surg. 2021 Dec 23. pii: 00000658-900000000-93132.
    PubMed     Abstract available


  27. LU C, Schardey J, Zhang T, Crispin A, et al
    Survival Outcomes and Clinicopathological Features in Inflammatory Bowel Disease-Associated Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93150.
    PubMed     Abstract available


  28. LAMBERT J, Hayes L, Keegan T, Subar D, et al
    Response to the Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis".
    Ann Surg. 2021;274:e932-e933.
    PubMed    


  29. ONERUP A, Angenete E, Haglind E
    Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-accordant Meta-analysis".
    Ann Surg. 2021;274:e932.
    PubMed    


  30. WANG J, Andreatos N, Margonis GA
    Comment on "RAS/TP53 co-Mutation is Associated With Worse Survival After Concurrent Resection of Colorectal Liver Metastases and Extrahepatic Disease".
    Ann Surg. 2021;274:e935-e936.
    PubMed    


  31. SHINALL MC JR, Beskow LM, Karlekar M, Martin SF, et al
    Psychosocial Stress Before Major Oncologic Operations: A Qualitative Content Analysis of Palliative Care Provider Documentation.
    Ann Surg. 2021;274:e649-e650.
    PubMed    


  32. LAMAZZA A, Carati M, Fiori E, Sterpetti AV, et al
    Comment on "Endoscopic Stenting and Diverting Colostomy as a Bridge to Surgery for Malignant Colorectal Obstruction." Balance Between Evidence-based Medicine and Personalized Therapy.
    Ann Surg. 2021;274:e874-e875.
    PubMed    


  33. ZHOU H, Tang Y, Hu Z
    Comment on "Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer".
    Ann Surg. 2021;274:e724.
    PubMed    


  34. WEI B, Zheng Z, Fang J, Xiao J, et al
    Effect of Denonvilliers' Fascia Preservation Versus Resection During Laparoscopic Total Mesorectal Excision on Postoperative Urogenital Function of Male Rectal Cancer Patients: Initial Results of Chinese PUF-01 Randomized Clinical Trial.
    Ann Surg. 2021;274:e473-e480.
    PubMed     Abstract available


  35. KAWAGUCHI Y, Newhook TE, Vauthey JN
    Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases".
    Ann Surg. 2021;274:e713-e714.
    PubMed    


  36. CRIPPA J, Grass F, Larson DW
    Response to the Comment on "Robotic Surgery for Rectal Cancer Provides Advantageous Outcomes Over Laparoscopic Approach".
    Ann Surg. 2021;274:e740.
    PubMed    


  37. ZHANG QX, Xu BB, Xue Z
    Comment on "Robotic Surgery for Rectal Cancer Provides Advantageous Outcomes Over Laparoscopic Approach: Results From a Large Retrospective Cohort".
    Ann Surg. 2021;274:e739-e740.
    PubMed    


  38. BERGAMASCHI R, Gachabayov M, Orangio G, Remzi F, et al
    Comment on "Local Recurrence After taTME for Rectal Cancer".
    Ann Surg. 2021;274:e727.
    PubMed    


  39. ROODBEEN SX, Spinelli A, Bemelman W, Di Candido F, et al
    Response to the Comment on "Local Recurrence After TaTME for Rectal Cancer".
    Ann Surg. 2021;274:e727-e729.
    PubMed    


  40. LANG H, Kloth M, Moehler M, Roth W, et al
    Response to the Comment on "Extended Molecular Profiling Improves Stratification and Prediction of Survival After Resection of Colorectal Liver Metastases".
    Ann Surg. 2021;274:e714.
    PubMed    


  41. SYN NL, Kabir T, Goh BKP
    Response to the Comment on "Survival Advantage of Laparoscopic Versus Open Resection for Colorectal Liver Metastases".
    Ann Surg. 2021;274:e730-e731.
    PubMed    


  42. VAN DER SANDE ME, Beets GL
    Response to the Comment on "Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer".
    Ann Surg. 2021;274:e724-e725.
    PubMed    


  43. PAN L, Fang J, Wang Y, Cai X, et al
    Comment on "Survival Advantage of Laparoscopic Versus Open Resection for Colorectal Liver Metastases".
    Ann Surg. 2021;274:e729-e730.
    PubMed    


  44. ZHANG QX, Xu BB, Xue Z
    Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2021;274:e689-e690.
    PubMed    


  45. BOLTON WS, Chapman SJ, Corrigan N, Croft J, et al
    The Incidence of Low Anterior Resection Syndrome as Assessed in an International Randomized Controlled Trial (MRC/NIHR ROLARR).
    Ann Surg. 2021;274:e1223-e1229.
    PubMed     Abstract available


  46. TRILLING B, Girard E, Faucheron JL
    Comment on "Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemoradiotherapy and Resection for Rectal Cancer".
    Ann Surg. 2021;274:e670-e671.
    PubMed    


  47. CRIPPA J, Grass F, Dozois EJ, Mathis KL, et al
    Robotic Surgery for Rectal Cancer Provides Advantageous Outcomes Over Laparoscopic Approach: Results From a Large Retrospective Cohort.
    Ann Surg. 2021;274:e1218-e1222.
    PubMed     Abstract available


  48. JANG JH, Kim HC
    Response to the Comment on "Anastomotic Leak Does Not Impact Oncologic Outcomes After Preoperative Chemotherapy and Resection for Rectal Cancer".
    Ann Surg. 2021;274:e671-e672.
    PubMed    


  49. VAN DER SANDE ME, Figueiredo N, Beets GL
    Management and Outcome of Local Regrowths in a Watch-and-wait Prospective Cohort for Complete Responses in Rectal Cancer.
    Ann Surg. 2021;274:e1056-e1062.
    PubMed     Abstract available


  50. VAN DER SANDE ME, Maas M, Melenhorst J, Breukink SO, et al
    Predictive Value of Endoscopic Features for a Complete Response After Chemoradiotherapy for Rectal Cancer.
    Ann Surg. 2021;274:e541-e547.
    PubMed     Abstract available


  51. KALTENMEIER C, Shen C, Medich DS, Geller DA, et al
    Time to Surgery and Colon Cancer Survival in the United States.
    Ann Surg. 2021;274:1025-1031.
    PubMed     Abstract available


  52. YOON JY, Mehta N, Burke CA, Augustin T, et al
    The Prevalence and Significance of Jejunal and Duodenal Bulb Polyposis After Duodenectomy in Familial Adenomatous Polyposis: Retrospective Cohort Study.
    Ann Surg. 2021;274:e1071-e1077.
    PubMed     Abstract available


    November 2021
  53. AUBERT M, Mege D, Parc Y, Rullier E, et al
    Surgical Management of Retrorectal Tumors: A French Multicentric Experience of 270 Consecutives Cases.
    Ann Surg. 2021;274:766-772.
    PubMed     Abstract available


    October 2021
  54. TAKII Y, Mizusawa J, Kanemitsu Y, Komori K, et al
    The Conventional Technique Versus the No-Touch Isolation Technique for Primary Tumor Resection in Patients With Colon Cancer (JCOG1006): A Multicenter, Open-Label, Randomized, Phase III Trial.
    Ann Surg. 2021 Oct 12. pii: 00000658-900000000-93231.
    PubMed     Abstract available


  55. CHIORESO C, Gao X, Gribovskaja-Rupp I, Lin C, et al
    Hospital and Surgeon Selection for Medicare Beneficiaries With Stage II/III Rectal Cancer: The Role of Rurality, Distance to Care, and Colonoscopy Provider.
    Ann Surg. 2021;274:e336-e344.
    PubMed     Abstract available


    September 2021
  56. LAMBERT J, Hayes L, Keegan T, Subar D, et al
    Response to: (Comment on "The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal and Upper Gastro-Intestinal Cancer Surgery: A PRISMA-Accordant Meta-Analysis").
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93254.
    PubMed    


  57. FIORE JF JR, Gillis C, Touma N, Elhaj H, et al
    Comment on: The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-analysis.
    Ann Surg. 2021 Sep 26. pii: 00000658-900000000-93253.
    PubMed    


  58. BOSTROM P, Hultberg DK, Haggstrom J, Haapamaki MM, et al
    Oncological Impact of High Vascular Tie After Surgery for Rectal Cancer: A Nationwide Cohort Study.
    Ann Surg. 2021;274:e236-e244.
    PubMed     Abstract available


    August 2021
  59. PLANELLAS P, Marinello F, Elorza G, Golda T, et al
    Extended Versus Standard Complete Mesocolon Excision in Sigmoid Colon Cancer: A Multicentre Randomised Controlled Trial.
    Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93319.
    PubMed     Abstract available


  60. BEHMAN R, Chesney T, Coburn N, Haas B, et al
    Minimally Invasive Compared to Open Colorectal Cancer Resection for Older Adults: A Population-based Analysis of Long-term Functional Outcomes.
    Ann Surg. 2021 Aug 19. pii: 00000658-900000000-93311.
    PubMed     Abstract available


  61. DONATI M, Zanatta M, Basile F
    Comments on "Strategy for Left sided Ostructive Colon Cancer": are we really writing the Epitaph of the three times approach?
    Ann Surg. 2021 Aug 11. pii: 00000658-900000000-93344.
    PubMed    


  62. LEE SY, Lee J, Park HM, Kim CH, et al
    Impact of Preoperative Immunonutrition on the Outcomes of Colon Cancer Surgery: Results from a Randomized Controlled Trial.
    Ann Surg. 2021 Aug 4. pii: 00000658-900000000-93357.
    PubMed     Abstract available


  63. YOU YN, Rodriguez-Bigas MA, Das P, Healy M, et al
    Comment on "A National Cancer Database Analysis of Microsatellite Instability and Pathologic Complete Response in Locally Advanced Rectal Cancer".
    Ann Surg. 2021;274:e197-e198.
    PubMed    


  64. ROODBEEN SX, Spinelli A, Bemelman WA, Di Candido F, et al
    Local Recurrence After Transanal Total Mesorectal Excision for Rectal Cancer: A Multicenter Cohort Study.
    Ann Surg. 2021;274:359-366.
    PubMed     Abstract available


  65. SYLLA P, Knol JJ, D'Andrea AP, Perez RO, et al
    Urethral Injury and Other Urologic Injuries During Transanal Total Mesorectal Excision: An International Collaborative Study.
    Ann Surg. 2021;274:e115-e125.
    PubMed     Abstract available


  66. MAO R, Li K, Cai JQ, Luo S, et al
    Adjuvant Chemotherapy Versus Observation Following Resection for Patients With Nonmetastatic Poorly Differentiated Colorectal Neuroendocrine Carcinomas.
    Ann Surg. 2021;274:e126-e133.
    PubMed     Abstract available


    July 2021
  67. LOUGHREY MB, Webster F, Arends MJ, Brown I, et al
    Dataset for Pathology Reporting of Colorectal Cancer: Recommendations from the International Collaboration on Cancer Reporting (ICCR).
    Ann Surg. 2021 Jul 7. pii: 00000658-900000000-93438.
    PubMed     Abstract available


    June 2021
  68. MARGONIS GA, Amini N, Buettner S, Kim Y, et al
    The Prognostic Impact of Primary Tumor Site Differs According to the KRAS Mutational Status: A Study By the International Genetic Consortium for Colorectal Liver Metastasis.
    Ann Surg. 2021;273:1165-1172.
    PubMed     Abstract available


    May 2021
  69. BALVARDI S, Pecorelli N, Castelino T, Niculiseanu P, et al
    Impact of Facilitation of Early Mobilization on Postoperative Pulmonary Outcomes After Colorectal Surgery: A Randomized Controlled Trial.
    Ann Surg. 2021;273:868-875.
    PubMed     Abstract available


    April 2021
  70. KEMENY NE, Chou JF, Capanu M, Chatila WK, et al
    A Randomized Phase II Trial of Adjuvant Hepatic Arterial Infusion and Systemic Therapy with or without Panitumumab after Hepatic Resection of KRAS Wild-Type Colorectal Cancer.
    Ann Surg. 2021 Apr 30. pii: 00000658-900000000-93567.
    PubMed     Abstract available


  71. ONERUP A, Andersson J, Angenete E, Bock D, et al
    Effect of Short-Term Homebased Pre- and Postoperative Exercise on Recovery after Colorectal Cancer Surgery (PHYSSURG-C): A Randomized Clinical Trial.
    Ann Surg. 2021 Apr 9. pii: 00000658-900000000-93606.
    PubMed     Abstract available


  72. CURTIS NJ, Dennison G, Brown CSB, Hewett PJ, et al
    Clinical Evaluation of Intraoperative Near Misses in Laparoscopic Rectal Cancer Surgery.
    Ann Surg. 2021;273:778-784.
    PubMed     Abstract available


    March 2021
  73. HASSELGREN K, Rosok BI, Larsen PN, Sparrelid E, et al
    ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO.
    Ann Surg. 2021;273:442-448.
    PubMed     Abstract available


    February 2021
  74. ISHIBE A, Watanabe J, Ota M, Endo I, et al
    Response to Comments on "A prospective, single-arm, multicenter trial of diverting stoma followed by neoadjuvant chemotherapy using mFOLFOX6 for obstructive colon cancer: YCOG1305 (PROBE study)".
    Ann Surg. 2021 Feb 26. doi: 10.1097/SLA.0000000000004824.
    PubMed    


  75. CAZELLES A, Manceau G, Taieb J, Karoui M, et al
    Comments On "A Prospective, Single-Arm, Multicenter Trial of Diverting Stoma Followed By Neoadjuvant Chemotherapy Using mFOLFOX6 for Obstructive Colon Cancer: YCOG 1305 (PROBE study)" Ann Surg 2020 [Epub ahead of print]. DOI: 10.1097/SLA.0000000000004
    Ann Surg. 2021 Feb 18. pii: 00000658-900000000-93710.
    PubMed    


  76. ZHANG Q, Chen B, Liu ZK
    Comment on "Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer, A Competing Risks Analysis".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93706.
    PubMed    


  77. DI BUONO G, Agrusa A
    Response to: Comment on "Feasibility and safety of laparoscopic Complete Mesocolic Excision (CME) for right-sided colon cancer: short-term outcomes. A randomized clinical study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93705.
    PubMed    


  78. LU JY, Xiao Y
    Comment on "Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-term Outcomes. A Randomized Clinical Study".
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93703.
    PubMed    


  79. STEIN SL
    Measure Twice, Cut Once.
    Ann Surg. 2021;273:195-196.
    PubMed    


    January 2021
  80. WATANABE J, Ishibe A, Suwa H, Ota M, et al
    Long-term Outcomes of a Randomized Controlled Trial of Single-incision Versus Multi-port Laparoscopic Colectomy for Colon Cancer.
    Ann Surg. 2021 Jan 28. doi: 10.1097/SLA.0000000000004252.
    PubMed     Abstract available


    December 2020
  81. QING Z, Liu ZY, Chen QY, Huang CM, et al
    Comment on: Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Dec 29. doi: 10.1097/SLA.0000000000004734.
    PubMed    


  82. HEALY MA, Peacock O, Hu CY, Bednarski BK, et al
    High Rate of Positive Circumferential Resection Margin in Colon Cancer: A National Appraisal and Call for Action.
    Ann Surg. 2020 Dec 22. doi: 10.1097/SLA.0000000000004682.
    PubMed     Abstract available


  83. OKUGAWA Y, Toiyama Y, Ohi M, Kusunoki M, et al
    Response to the Comment on "Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    


  84. KUDOSE Y, Ahiko Y, Shida D
    Response to: Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    


  85. WANG X, Zheng Z, Chi P
    Comment on "Evaluation of Recurrence Risk After Curative Resection for Patients With Stage I to III Colorectal Cancer Using the Hazard Function: Retrospective Analysis of a Single-institution Large Cohort".
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed    


  86. DENG X, Liu P, Jiang D, Wei M, et al
    Neoadjuvant Radiotherapy Versus Surgery Alone for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors: A Prospective Multicenter Stratified Randomized Trial.
    Ann Surg. 2020;272:1060-1069.
    PubMed     Abstract available


  87. YAMASHITA S, Chun YS, Kopetz SE, Maru D, et al
    APC and PIK3CA Mutational Cooperativity Predicts Pathologic Response and Survival in Patients Undergoing Resection for Colorectal Liver Metastases.
    Ann Surg. 2020;272:1080-1085.
    PubMed     Abstract available


    November 2020
  88. POULSON M, Cornell E, Madiedo A, Kenzik K, et al
    The Impact of Racial Residential Segregation on Colorectal Cancer Outcomes and Treatment.
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004653.
    PubMed     Abstract available


  89. TRILLING B, Delattre F, Faucheron JL
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004403.
    PubMed    


  90. GAO Z, Wang C, Jiang K, Shen Z, et al
    Response to the Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results from a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004394.
    PubMed    


  91. GAO Z, Wang C, Tao Z, Ye Y, et al
    Response to Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-year Results From a Prospective, Nonrandomized, Double-blind, Controlled Trial".
    Ann Surg. 2020 Nov 23. doi: 10.1097/SLA.0000000000004273.
    PubMed    


  92. ZHU D, Xia J, Gu Y, Lin J, et al
    Preoperative Hepatic and Regional Arterial Chemotherapy in Patients Who Underwent Curative Colorectal Cancer Resection: A Prospective, Multi-Center, Randomized Controlled Trial.
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004558.
    PubMed     Abstract available


  93. LAMBERT J, Hayes L, Keegan T, Subar D, et al
    The Impact of Prehabilitation on Patient Outcomes in Hepatobiliary, Colorectal, and Upper Gastrointestinal Cancer Surgery: A PRISMA-Accordant Meta-Analysis.
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004527.
    PubMed     Abstract available


  94. DI BUONO G, Buscemi S, Cocorullo G, Sorce V, et al
    Feasibility and Safety of Laparoscopic Complete Mesocolic Excision (CME) for Right-Sided Colon Cancer: Short-Term Outcomes. A Randomized Clinical Study.
    Ann Surg. 2020 Nov 9. doi: 10.1097/SLA.0000000000004557.
    PubMed     Abstract available


  95. PETROWSKY H, Linecker M, Raptis DA, Kuemmerli C, et al
    First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases.
    Ann Surg. 2020;272:793-800.
    PubMed     Abstract available


  96. IGNATAVICIUS P, Oberkofler CE, Chapman WC, DeMatteo RP, et al
    Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice?
    Ann Surg. 2020;272:715-722.
    PubMed     Abstract available


  97. AREZZO A, Forcignano E, Bonino MA, Balague C, et al
    Long-term Oncologic Results After Stenting as a Bridge to Surgery Versus Emergency Surgery for Malignant Left-sided Colonic Obstruction: A Multicenter Randomized Controlled Trial (ESCO Trial).
    Ann Surg. 2020;272:703-708.
    PubMed     Abstract available


    October 2020
  98. GLEASON F, Chu DI, Kennedy GD, Kenzik KM, et al
    Early Elective Surgery After Colon Cancer Diagnosis has Higher Risk of Readmission and Death.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004431.
    PubMed     Abstract available


  99. NG KS, Dent OF, Chan C, Newland RC, et al
    Apical Node Involvement Does Not Influence Prognosis After Potentially Curative Resection for Stage III Colorectal Cancer: A Competing Risks Analysis.
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004353.
    PubMed     Abstract available


  100. SOUADKA A, Majbar MA, Essangri H, Benkabbou A, et al
    Comment on "Efficacy and Safety of Complete Mesocolic Excision in Patients With Colon Cancer: Three-Year Results From a Prospective, Nonrandomized, Double-Blind, Controlled Trial".
    Ann Surg. 2020 Oct 14. doi: 10.1097/SLA.0000000000004284.
    PubMed    


    July 2020
  101. ARRINGTON AK, O'Grady C, Schaefer K, Khreiss M, et al
    Significance of Lymph Node Resection After Neoadjuvant Therapy in Pancreatic, Gastric, and Rectal Cancers.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004181.
    PubMed     Abstract available


    June 2020
  102. DUELAND S, Line PD
    Response to Comment on "Survival Following Liver Transplantation for Patients with Nonresectable Liver-only Colorectal Metastases".
    Ann Surg. 2020 Jun 3. doi: 10.1097/SLA.0000000000003953.
    PubMed    


    May 2020
  103. JEGATHEESWARAN S, Siriwardena AK
    Comment on "Survival After Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases".
    Ann Surg. 2020 May 8. doi: 10.1097/SLA.0000000000003960.
    PubMed    


    September 2019
  104. GORGEN A, Sapisochin G
    Comment on "Survival Following Liver Transplantation for Patients With Nonresectable Liver-only Colorectal Metastases": What if Those Lesions are Gone?
    Ann Surg. 2019 Sep 24. doi: 10.1097/SLA.0000000000003606.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: